会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明授权
    • Avermectin and avermectin monosaccharide derivatives substituted in the 4″-or 4′-position having pesticidal properties
    • 在4“ - 或4”位取代的具有杀虫性的阿维菌素和阿维菌素单糖衍生物
    • US07678740B2
    • 2010-03-16
    • US10543637
    • 2004-01-30
    • Thomas PitternaFiona Murphy KessabiPeter MaienfischJerome CassayreLaura QuarantaPierre Jung
    • Thomas PitternaFiona Murphy KessabiPeter MaienfischJerome CassayreLaura QuarantaPierre Jung
    • A01N25/26A01N43/02A01N43/04C07H17/08
    • A01N43/90C07H17/08
    • What is described are a compound of the formula (I) Wherein U is —N(R2)OR3 or —N+(O−)═C(RE)RZ); n is 0 or 1; X—Y is —CH═CH— or —CH2—CH2—; R1 is C1-C12alkyl, C3-C8cycloalkyl or C2-C12alkenyl; R2 and R3 are, for example; independently from each other, —Q, —C(═O)—Z—Q or —CN; RZ and RE are, independently from each other, —Q, —C(═O)—Z—Q or —CN; or RZ and RE together are a three- to seven membered alkylene or alkenylene bridge, which is unsubstituted or mono- to tri-substituted; Z is a bond, O or —NR4—; Q is H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12-Cycloalkyl, C5-C12-cycloalkenyl, aryl, or heterocyclyl, which are unsubstituted or mono- to pentasubstituted; R4 is for example H, C1-C8alkyl, hydroxy-C1-C8alkyl, C3-C8cycloalkyl or C2-C8alkenyl; or, if appropriate, an E/Z isomer, E/Z isomer mixture and/or tautomer thereof; a process for preparing these compounds, their isomers and tautomers and the use of these compounds, their isomers and tautomers; pesticidal compositions whose active compound is selected from these compounds and their tautomers; intermediates for the preparation of the said compounds of the formula (I), methods for the preparation of the compounds of the formula (I), and a method for controlling pests using these compositions.
    • 描述的是式(I)的化合物,其中U是-N(R 2)OR 3或-N +(O-)= C(RE)R Z); n为0或1; X-Y是-CH = CH-或-CH 2 -CH 2 - ; R1是C1-C12烷基,C3-C8环烷基或C2-C12链烯基; R2和R3例如是: 独立地为-Q,-C(= O)-Z-Q或-CN; RZ和RE彼此独立地为-Q,-C(= O)-Z-Q或-CN; 或RZ和RE一起是三至七元的亚烷基或亚烯基桥,其是未取代的或一至三取代的; Z是O或-NR4-键; Q是未被取代或被一取代或五取代的H,C 1 -C 12烷基,C 2 -C 12烯基,C 2 -C 12炔基,C 3 -C 12环烷基,C 5 -C 12 - 环烯基,芳基或杂环基, R4是例如H,C1-C8烷基,羟基-C1-C8烷基,C3-C8环烷基或C2-C8链烯基; 或者,如果合适的话,E / Z异构体,E / Z异构体混合物和/或其互变异构体; 制备这些化合物,其异构体和互变异构体的方法以及这些化合物,其异构体和互变异构体的用途; 活性化合物选自这些化合物及其互变异构体的杀虫组合物; 用于制备所述式(I)化合物的中间体,式(I)化合物的制备方法和使用这些组合物来控制害虫的方法。
    • 66. 发明授权
    • Anthelmintic oral homogeneous veterinary pastes
    • 驱虫药口服同类兽药
    • US07563773B2
    • 2009-07-21
    • US11107048
    • 2005-04-15
    • Keith FreehaufMaryam Moaddeb
    • Keith FreehaufMaryam Moaddeb
    • A01N43/04A61K31/70A61K31/495
    • A61K31/498A61K9/0056A61K31/7048A61K2300/00
    • This invention provides for, inter alia, oral homogeneous veterinary pastes for the treating, controlling and preventing of endo- and ectoparasite infections in warm-blooded animals or birds, such as horses and household pets. This invention further provides for a process of preparing these veterinary pastes and for a method for increasing the bioavailability of the anthelmintic agents contained in the paste in the warm-blooded animal or bird. The inventive oral homogeneous anthelmintic pastes comprise a first anthelmintic agent, for example, prazequantel and/or pyrantel, and at least one marcrolide anthelmintic compound, a solvent, which dissolves both the first anthelmintic agent and second the macrolide anthelmintic compound, and a thickening agent. The inventive oral homogeneous pastes achieve a better bioavailability of the two active anthelmintic agents than when the two actives are in suspension and not dissolved
    • 本发明特别提供了用于治疗,控制和预防温血动物或鸟类如马和家庭宠物中的内寄生虫和外寄生虫感染的口腔同质兽药。 本发明进一步提供了制备这些兽用糊剂的方法和用于增加包含在温血动物或鸟类中的糊剂中的驱肠剂的生物利用度的方法。 本发明的口腔均匀驱肠药膏包括第一驱肠虫剂,例如赞夸酮和/或吡柔比星,以及至少一种扑灭姜黄素的驱肠虫化合物,溶解第一驱肠虫剂和第二大环内酯类驱虫剂化合物的溶剂,以及增稠剂 。 与两种活性物质悬浮并不溶解时相比,本发明的口服均质膏实现了两种活性驱肠虫剂的更好的生物利用度
    • 68. 发明授权
    • Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
    • 包含1-N-芳基吡唑衍生物和氨基拉唑的局部制剂
    • US07531186B2
    • 2009-05-12
    • US10783459
    • 2004-02-20
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • Albert BoeckhLuiz Gustavo CramerMark D. Soll
    • A01N25/32
    • A01N43/56A01N47/02A01N2300/00A01N37/52
    • The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.
    • 本发明特别提供了包含至少一种1-N-阿吡唑衍生物和氨喋啶的新型局部制剂,以及用于治疗,控制或预防哺乳动物或鸟类寄生虫侵袭的方法。本发明的制剂包括点状, 可以包括另外的外寄生物杀虫剂,例如IGR化合物,除虫菌素或米尔倍霉素衍生物,拟除虫菊酯杀虫剂,以及驱肠虫药如苯并咪唑和咪唑并噻唑。 本发明的配方以更快的控制速率提供更大的寄生虫控制持续时间。 本发明的公式从第一次申请至多三个月仍然有效。 此外,本发明的制剂防止蜱附着于动物,从而提供防止蜱携带疾病的保护。 本发明可以控制,治疗或预防的外寄生虫包括蜱,跳蚤,螨虫,虱子,虱子,蚊子,苍蝇和牛。。。